{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:51:23Z","timestamp":1785783083436,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06545-3","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:08:25Z","timestamp":1762157305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Response to anticholinergic therapy and its predictors in pediatric overactive bladder"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-5960","authenticated-orcid":false,"given":"Furkan Adem","family":"Canbaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"6545_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/NAU.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin PF, Bauer SB, Bower W et al (2016) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children\u2019s Continence Society. Neurourol Urodyn 35:471\u2013481. https:\/\/doi.org\/10.1002\/NAU.22751","journal-title":"Neurourol Urodyn"},{"key":"6545_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5213\/inj.2244228.114","volume":"27","author":"J Shim","year":"2023","unstructured":"Shim J, Oh MM (2023) Updates of overactive bladder in pediatrics. Int Neurourol J 27:3\u201314. https:\/\/doi.org\/10.5213\/inj.2244228.114","journal-title":"Int Neurourol J"},{"key":"6545_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/nau.24251","volume":"39","author":"D Xing","year":"2020","unstructured":"Xing D, Wang YH, Wen YB (2020) Prevalence and risk factors of overactive bladder in Chinese children: a population-based study. Neurourol Urodyn 39:688\u2013694. https:\/\/doi.org\/10.1002\/nau.24251","journal-title":"Neurourol Urodyn"},{"key":"6545_CR4","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.5489\/cuaj.4337","volume":"11","author":"S Ramsay","year":"2017","unstructured":"Ramsay S, Bolduc S (2017) Overactive bladder in children. Can Urol Assoc J 11:S74\u2013S79. https:\/\/doi.org\/10.5489\/cuaj.4337","journal-title":"Can Urol Assoc J"},{"key":"6545_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00431-020-03681-w","volume":"179","author":"S Tekgul","year":"2020","unstructured":"Tekgul S, Stein R, Bogaert G et al (2020) EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children. Eur J Pediatr 179:1069\u20131077. https:\/\/doi.org\/10.1007\/s00431-020-03681-w","journal-title":"Eur J Pediatr"},{"key":"6545_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2021.11.013","volume":"18","author":"AS Jessen","year":"2022","unstructured":"Jessen AS, Hagstroem S, Borch L (2022) Comparison and characteristics of children successfully treated for daytime urinary incontinence. J Pediatr Urol 18:24.e1-24.e9. https:\/\/doi.org\/10.1016\/j.jpurol.2021.11.013","journal-title":"J Pediatr Urol"},{"key":"6545_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.29271\/jcpsp.2020.01.41","volume":"30","author":"C Wei","year":"2020","unstructured":"Wei C, Gao J, Kou L et al (2020) Can urodynamic findings of overactive bladder determine the treatment effect of urotherapy in children? J Coll Physicians Surg Pak 30:41\u201345. https:\/\/doi.org\/10.29271\/jcpsp.2020.01.41","journal-title":"J Coll Physicians Surg Pak"},{"key":"6545_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40124-024-00329-3","volume":"12","author":"KC Rivera","year":"2024","unstructured":"Rivera KC, Rickard M, Varghese A et al (2024) Bladder and bowel dysfunction: an updated guide for the pediatrician and pediatric nephrologist. Curr Pediatr Rep\u00a0https:\/\/doi.org\/10.1007\/s40124-024-00329-3","journal-title":"Curr Pediatr Rep"},{"key":"6545_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5213\/inj.2011.15.4.206","volume":"15","author":"JH Kim","year":"2011","unstructured":"Kim JH, Lee JH, Jung AY, Lee JW (2011) The prevalence and therapeutic effect of constipation in pediatric overactive bladder. Int Neurourol J 15:206\u2013210. https:\/\/doi.org\/10.5213\/inj.2011.15.4.206","journal-title":"Int Neurourol J"},{"key":"6545_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5489\/cuaj.7811","volume":"16","author":"\u00c9 Lapointe","year":"2022","unstructured":"Lapointe \u00c9, Singbo N, Naud \u00c9, Bolduc S (2022) First North American experience of propiverine use in children with overactive bladder. Can Urol Assoc J 16:358\u2013363. https:\/\/doi.org\/10.5489\/cuaj.7811","journal-title":"Can Urol Assoc J"},{"key":"6545_CR11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3346\/jkms.2014.29.11.1550","volume":"29","author":"SJ Park","year":"2014","unstructured":"Park SJ, Pai KS, Kim JM et al (2014) Efficacy and tolerability of anticholinergics in Korean children with overactive bladder: a multicenter retrospective study. J Korean Med Sci 29:1550\u20131554. https:\/\/doi.org\/10.3346\/jkms.2014.29.11.1550","journal-title":"J Korean Med Sci"},{"key":"6545_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00345-013-1224-y","volume":"32","author":"C Akbal","year":"2014","unstructured":"Akbal C, \u015eahan A, \u015eener TE et al (2014) Diagnostic value of the pediatric lower urinary tract symptom score in children with overactive bladder. World J Urol 32(1):201\u2013208. https:\/\/doi.org\/10.1007\/s00345-013-1224-y","journal-title":"World J Urol"},{"key":"6545_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1590\/S1677-5538.IBJU.2015.0579","volume":"42","author":"AS Sousa","year":"2016","unstructured":"Sousa AS, Veiga ML, Braga AAN et al (2016) Enuresis and overactive bladder in children: what is the relationship between these two conditions? Int Braz J Urol 42:798\u2013802. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2015.0579","journal-title":"Int Braz J Urol"},{"key":"6545_CR14","doi-asserted-by":"publisher","unstructured":"Capdevila Vilar\u00f3 B, Casal-Beloy I, Villal\u00f3n Ferrero FN et al (2024) Caracterizaci\u00f3n y tratamiento de la enuresis en pacientes con vejiga hiperactiva. Cir Pediatr 37:27\u201332. https:\/\/doi.org\/10.54847\/cp.2024.01.14","DOI":"10.54847\/cp.2024.01.14"},{"key":"6545_CR15","doi-asserted-by":"publisher","unstructured":"Ko\u00e7 B, Canpolat N, Adaletli \u0130 et al (2020) Efficacy of tolterodine in children with overactive bladder. Turk Arch Pediatr 55:284\u2013289. https:\/\/doi.org\/10.14744\/TurkPediatriArs.2020.98215","DOI":"10.14744\/TurkPediatriArs.2020.98215"},{"key":"6545_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.eururo.2003.10.009","volume":"45","author":"A Raes","year":"2004","unstructured":"Raes A, Hoebeke P, Segaert I et al (2004) Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder. Eur Urol 45:240\u2013244. https:\/\/doi.org\/10.1016\/j.eururo.2003.10.009","journal-title":"Eur Urol"},{"key":"6545_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1464-410X.2009.09129.x","volume":"106","author":"S Alloussi","year":"2010","unstructured":"Alloussi S, M\u00fcrtz G, Braun R et al (2010) Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: results of a multicentre observational cohort study. BJU Int 106:550\u2013556. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.09129.x","journal-title":"BJU Int"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06545-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:35:35Z","timestamp":1762846535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06545-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6545"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06545-3","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital Ethics Committee (Date:\u00a008.01.2025\/No:\u00a02025\/12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"727"}}